Quarterly report pursuant to Section 13 or 15(d)

CONDENSED BALANCE SHEETS

v3.22.1
CONDENSED BALANCE SHEETS - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Current assets:    
Cash $ 1,442,523 $ 1,722,506
Prepaid expenses 661,000 812,724
Total current assets 2,103,523 2,535,230
Investments held in Trust Account 171,700,181 171,656,153
Total Assets 173,803,704 174,191,383
Current liabilities:    
Accounts payable 77,991 51,807
Accrued expenses 2,035,683 1,656,137
Franchise tax payable 79,676 185,205
Total current liabilities 2,193,350 1,893,149
Derivative warrant liability 2,880,140 5,571,410
Deferred underwriting commissions in connection with the initial public offering 6,006,525 6,006,525
Total Liabilities 11,080,015 13,471,084
Commitments and Contingencies
Stockholders' Deficit:    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding as of March 31, 2022 and December 31, 2021
Common stock, $0.0001 par value; 400,000,000 shares authorized; 4,290,375 shares issued and outstanding as of March 31, 2022 and December 31, 2021 (excluding 17,161,500 shares subject to possible redemption) 429 429
Accumulated deficit (8,891,740) (10,895,130)
Total stockholders' deficit (8,891,311) (10,894,701)
Total Liabilities, Common Stock Subject to Possible Redemption and Stockholders' Deficit 173,803,704 174,191,383
Common Stock Subject to Redemption    
Current liabilities:    
Common stock subject to possible redemption; 17,161,500 shares at redemption value of $10.00 per share as of March 31, 2022 and December 31, 2021 $ 171,615,000 $ 171,615,000